Japan generic drugs market is anticipated to grow with an impressive CAGR in the forecast period, FY2023-FY2027. The market is expected to grow with the projected cumulative annular growth rate on the account of surging demand for biosimilar drugs. Increased medical expenses due to aging population and their demands for the best effective healthcare services. Japan is the largest pharmaceutical market in the world. Demand for the effective healthcare services is also driving the growth of the Japan generic drugs market in the upcoming five years. Additionally, government support to the generic drugs and supporting the lower-cost copycat products is further supporting the growth of the Japan generic drugs market in the upcoming five years. Oncology therapies, drugs for diabetes and immunosuppressive agents are expected to substantiate the growth of the Japan generic drugs market in the future five years. Due to increasing cost of healthcare services the government is desperately trying to adopt to various methods such that best possible healthcare services can be provided at more affordable cost as well as to overcome the national debt that is estimated to be double than the country’s GDP, these factors are also anticipated to show robust growth of the Japan generic drugs market in the forecast period, until 2026.
The Japan generic drugs market segmentation is based on type, mode of drug delivery, form, source, distribution channel, application, regional distribution, top 3 states analysis in each region, and competitional landscape. Based on type, the market is divided between small molecule generics, and biosimilars. Biosimilars is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the account of surging demand for the advanced biosimilars. Cost-effective nature of biosimilars and rising acceptance and adoption by stake holders is further driving the growth of the Japan generic drugs market in the next five years. Moreover, growing prevalence of chronic diseases and the demand to overcome these diseases is further substantiating the growth of the Japan generic drugs market in the future five years.
Some of the top players in the Japan generic drugs market is Nichi-Iko Pharmaceutical Co., Ltd., Sawai Pharmaceutical Co., Ltd., Towa Pharmaceutical Co., Ltd., Nipro Corporation, Daiichi Sankyo Co., Ltd., Meiji Holdings Co., Ltd., Nihon Chouzai Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Aska Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc, Otsuka Pharmaceutical Co., Ltd., among others. Major market players are actively dedicated in the research and development of the advanced products such that the consumer’s demand could be fulfilled. Consistent research ensures the future launches for the better products and services. With rapidly surging demand for the advanced products, the new market entrants would be able to establish their brand and thus their market-place. Other strategies include collaborations and partnerships with the pre-existing market players or the research institutes such that government funding can be availed for the product development.
Years considered for this report
Historical YearsFY2017 – FY2020
Base YearFY2021
Estimated YearFY2022
Forecast PeriodFY2023 – FY2027
Objective of the Study
- To analyze the historical growth of the market size of Japan generic drugs market from FY2017 to FY2020.
- To estimate and forecast the market size of Japan generic drugs market from FY2021 to FY2027 and growth rate until FY2027.
- To classify and forecast Japan generic drugs market based on type, mode of drug delivery, form, source, distribution channel, application, regional distribution, top 3 states analysis in each region, and competitional landscape.
- To identify dominant region or segment in the Japan generic drugs market.
- To identify drivers and challenges for Japan generic drugs market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Japan generic drugs market.
- To identify and analyze the profile of leading players operating in Japan generic drugs market.
- To identify key sustainable strategies adopted by market players in Japan generic drugs market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of Japan
Key Target Audience
- Generic drugs manufacturers, end users, and other stakeholders
- Distributers and suppliers of Generic drugs and other stakeholders
- Organizations, forums and alliances related to generic drugs
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
